Your session is about to expire
← Back to Search
Androgen Receptor Inhibitor
Lower DMAU + LNG for Men
Phase 2
Waitlist Available
Research Sponsored by Health Decisions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial is testing a new medication to see if it suppresses spermatogenesis ( sperm production) in healthy men. The medication will be given for 12 weeks.
Eligible Conditions
- Men
- Male Birth Control
- Healthy Subjects
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
5Treatment groups
Experimental Treatment
Placebo Group
Group I: Middle DMAU + PlaceboExperimental Treatment2 Interventions
DMAU 200 mg + placebo administered orally in capsules.
Group II: Middle DMAU + LNGExperimental Treatment2 Interventions
DMAU 200 mg + LNG 30 mcg administered orally in capsules.
Group III: Lower DMAU + LNGExperimental Treatment2 Interventions
DMAU 100 mg + LNG 30 mcg administered orally in capsules.
Group IV: Higher DMAU + PlaceboExperimental Treatment2 Interventions
DMAU 400 mg + placebo administered orally in capsules.
Group V: PlaceboPlacebo Group1 Intervention
Placebo administered orally capsules.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo oral capsule
2010
Completed Phase 4
~2380
Find a Location
Who is running the clinical trial?
Health DecisionsLead Sponsor
30 Previous Clinical Trials
13,797 Total Patients Enrolled
1 Trials studying Men
420 Patients Enrolled for Men
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterOTHER
104 Previous Clinical Trials
46,483 Total Patients Enrolled
1 Trials studying Men
100 Patients Enrolled for Men
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,014 Previous Clinical Trials
2,696,734 Total Patients Enrolled
2 Trials studying Men
520 Patients Enrolled for Men
Share this study with friends
Copy Link
Messenger